Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Garden State Life Sciences Venture Fund was a $10 million venture capital vehicle established by the New Jersey Economic Development Authority (NJEDA) to support early-stage life sciences companies within the state. Managed by Quaker BioVentures, the fund focused on providing equity capital to startups in the biotechnology, pharmaceutical, and medical device sectors. The initiative was a key component of New Jersey's Edison Innovation Fund, aimed at leveraging the state's extensive pharmaceutical infrastructure and academic research to foster a local innovation ecosystem. By bridging the funding gap for young companies, the fund sought to accelerate the commercialization of new medical technologies and therapies. It typically targeted companies that had already secured initial capital and were looking to advance toward clinical or commercial milestones.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Garden State Life Sciences Venture Fund.